Gene: PDE1C
Official Full Name: phosphodiesterase 1Cprovided by HGNC
Gene Summary: This gene encodes an enzyme that belongs to the 3'5'-cyclic nucleotide phosphodiesterase family. Members of this family catalyze hydrolysis of the cyclic nucleotides, cyclic adenosine monophosphate and cyclic guanosine monophosphate, to the corresponding nucleoside 5'-monophosphates. The enzyme encoded by this gene regulates proliferation and migration of vascular smooth muscle cells, and neointimal hyperplasia. This enzyme also plays a role in pathological vascular remodeling by regulating the stability of growth factor receptors, such as PDGF-receptor-beta. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07955 | PDE1C Knockout cell line (HeLa) | Human | PDE1C | 1:3~1:6 | Negative | Online Inquiry |
KO07956 | PDE1C Knockout cell line (A549) | Human | PDE1C | 1:3~1:4 | Negative | Online Inquiry |
PDE1C Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to disrupt the expression of the phosphodiesterase 1C (PDE1C) gene. This product is pivotal for researchers aiming to elucidate the role of PDE1C in various physiological and pathological processes. Phosphodiesterases are critical enzymes involved in the hydrolysis of cyclic nucleotides, thereby regulating key cellular signaling pathways. By utilizing these knockout cell lines, researchers can investigate the physiological implications of PDE1C deficiency, particularly in the context of cardiovascular diseases, neurodegenerative disorders, and cancer.
The unique mechanism of action inherent to these cell lines lies in their ability to mimic specific pathological states. Without functional PDE1C, intracellular levels of cyclic AMP and cyclic GMP may increase, subsequently impacting numerous downstream signaling cascades. This model provides invaluable insights into the PDE1C involvement in cellular responses, drug interactions, and therapeutic implications.
In terms of scientific importance, PDE1C Gene Knockout Cell Lines are indispensable tools in both basic and applied research. Their utilization extends to drug development, where they can be employed for screening novel PDE inhibitors, as well as in studies investigating the implications of PDE1C in disease mechanisms. They facilitate the exploration of therapeutic targets and can accelerate the translation of findings into clinical applications.
Compared to conventional cell models, these genetically modified cell lines offer unparalleled specificity and reliability in studying PDE1C functions. Their precise manipulation of the PDE1C gene allows for the resolution of confounding factors that often complicate experimental outcomes.
For researchers and clinicians in the fields of pharmacology, molecular biology, and regenerative medicine, PDE1C Gene Knockout Cell Lines represent a powerful asset. They enable in-depth investigation of key pathways and potential therapeutic targets, fostering innovation in drug discovery and fundamental research.
With a commitment to scientific excellence, our company specializes in providing high-quality biological products designed to advance research and therapeutic development. Our expertise in genetic engineering ensures that our cell lines meet rigorous standards for quality and reproducibility, empowering our clients to achieve their research objectives efficiently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.